TrialDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2023

Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial.

Golbarg Alavian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.